A card game could open the door to better End-of-Life conversations

NCT ID NCT06384417

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study tests whether a conversation game called 'Hello' can help people with cancer and their loved ones discuss advance care planning—decisions about future medical care. Participants will play either the Hello game or a similar conversation game, complete questionnaires, and join focus groups. The goal is to see if the game is acceptable and useful, and whether it affects healthcare use like hospital visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hello for Cancer game
What this could lead to
If effective, this game could become a simple tool to help cancer patients and families have important conversations about care preferences, potentially improving quality of life and reducing unwanted hospitalizations.
What could go wrong
This is a small, early-stage study focused on feasibility and adaptation, so results may not be generalizable. The game may not change actual healthcare decisions or outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Penn State Cancer Institute

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.